(NASDAQ: EMBC) Embecta's forecast annual revenue growth rate of 0.55% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Embecta's revenue in 2026 is $1,079,700,000.On average, 6 Wall Street analysts forecast EMBC's revenue for 2026 to be $64,727,300,422, with the lowest EMBC revenue forecast at $62,180,846,700, and the highest EMBC revenue forecast at $66,681,555,604. On average, 6 Wall Street analysts forecast EMBC's revenue for 2027 to be $64,668,080,568, with the lowest EMBC revenue forecast at $61,529,428,306, and the highest EMBC revenue forecast at $67,155,314,436.
In 2028, EMBC is forecast to generate $65,082,619,546 in revenue, with the lowest revenue forecast at $62,299,286,408 and the highest revenue forecast at $67,392,193,852.